Cardiac Science Corporation

Cardiac Science Corporation is a global leader in the development, manufacture and marketing of diagnostic and therapeutic cardiology products and services. Formed by the merger of Cardiac Science, Inc. and Quinton Cardiology Systems in September 2005, the predecessor companies have a rich legacy of technology development in the market for cardiology devices.

Cardiac Science Corporation provides a full spectrum of cardiology products and services that help protect hearts and save lives. From devices designed to identify the early stages of heart disease-such as Electrocardiographs, Cardiac Stress Testing Systems, and Holter Monitors-to sophisticated systems that enable Cardiac Rehabilitation and Cardiology Data Management-to innovative and patented automated external defibrillators (AEDs) that provide assistance to victims of sudden cardiac arrest for both medical and non-medical markets.

Our products are marketed under the Burdick®, Powerheart® and Quinton® brand names.

Worldwide Reach

Cardiac Science employs more than 550 people worldwide. The Company has extensive global capabilities with direct and indirect sales personnel, distribution in over 160 countries and an extensive worldwide service network.

Headquartered near Seattle, Washington, the company also has operations in California, Wisconsin, China, Denmark and the United Kingdom. Cardiac Science shares are traded on the NASDAQ national market, under the trading symbol "CSCX."

"At the Heart of Saving Lives"